Human milk oligosaccharides (HMOs) – abundant in human milk – are known for helping protect breastfed infants from pathogens and for shaping their gut microbiota.
Now, researchers have found that HMOs could be as effective as the broad-spectrum antibiotics traditionally prescribed to pregnant women to prevent Group B Streptococcus from being passed to their newborns and causing serious bacterial infections.
See their full findings, just published by the American Society for Microbiology in this open access article: 'Human Milk Oligosaccharides Reduce Murine Group B Streptococcus Vaginal Colonization with Minimal Impact on the Vaginal Microbiota'.
FLRF is a proud contributor to this promising research, through the MOMI Seeds grant program for early stage, multidisciplinary research offered by the Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (MOMI CORE) at the University of California San Diego.
Care to discover more about other projects sprouting from MOMI Seeds and MOMI CORE? Subscribe to our newsletter.